Scheich - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Scheich

Showing results (381-390 of 384) with videos related to

Pageof 39

Sort By:

You have reached the last page of results.This site can display upto 384 results.

Cancer Cell|June 4, 2026

Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.

Blood|October 8, 2021

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.

Haematologica|April 2, 2026

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphomaEvgenii Shumilov, Rebecca Wurm-Kuczera, Joseph Kauer, et al.

Journal of Medicinal Chemistry|July 15, 2020

Imaging Mutant Huntingtin Aggregates: Development of a Potential PET LigandLongbin Liu, Michael E Prime, Matt R Lee, et al.

Pageof 39

Search research articles

Showing results (381-390 of 384) with videos related to

Sort By:

Pageof 39

You have reached the last page of results.This site can display upto 384 results.

Cancer Cell|June 4, 2026

Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.

Blood|October 8, 2021

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.

Haematologica|April 2, 2026

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphomaEvgenii Shumilov, Rebecca Wurm-Kuczera, Joseph Kauer, et al.

Journal of Medicinal Chemistry|July 15, 2020

Imaging Mutant Huntingtin Aggregates: Development of a Potential PET LigandLongbin Liu, Michael E Prime, Matt R Lee, et al.

Pageof 39